Kura Oncology (KURA) Non Operating Income (2014 - 2026)

Kura Oncology (KURA) has 13 years of Non Operating Income data on file, last reported at $5.5 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at $5.5 million, down 26.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.7 million (changed 0.32% YoY), and the FY2025 annual result was $25.3 million, up 18.99% from the prior year.
• Non Operating Income retreated to $5.5 million in Q1 2026 per KURA's latest filing, from $7.5 million in the prior quarter.
• Over five years, Non Operating Income peaked at $7.5 million in Q1 2025 and troughed at $329000.0 in Q1 2022.
• A 5-year average of $3.7 million and a median of $3.9 million in 2023 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2026: Non Operating Income jumped 3625.0% in 2022, then decreased 26.77% in 2026.
• A 5-year view of Non Operating Income shows it stood at $2.0 million in 2022, then jumped by 94.71% to $4.0 million in 2023, then jumped by 32.19% to $5.3 million in 2024, then soared by 42.64% to $7.5 million in 2025, then declined by 26.77% to $5.5 million in 2026.
• Business Quant data shows KURA's Non Operating Income at $5.5 million in Q1 2026, $7.5 million in Q1 2025, and $5.3 million in Q4 2024.